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ront–rear asymmetry in motile cells is crucial for ef-
ﬁcient directional movement. The uropod in migrating
lymphocytes is a posterior protrusion in which sev-
eral proteins, including CD44 and ezrin/radixin/moesin
(ERM), are concentrated. In EL4.G8 T-lymphoma cells,
Thr567 phosphorylation in the COOH-terminal domain
of ezrin regulates the selective localization of ezrin in the
uropod. Overexpression of the phosphorylation-mimetic
T567D ezrin enhances uropod size and cell migration.
T567D ezrin also induces construction of the CD44-asso-
ciated polar cap, which covers the posterior cytoplasm in
staurosporine-treated, uropod-disrupted EL4.G8 cells or
F
 
in naturally unpolarized X63.653 myeloma cells in
an actin cytoskeleton–dependent manner. Rho-associated
coiled coil–containing protein kinase (ROCK) inhibitor
Y-27632 disrupts the uropod but not the polar cap, indi-
cating that Rho–ROCK signaling is required for posterior
protrusion but not for ERM phosphorylation. Phosphory-
lated ezrin associates with Dbl through its NH
 
2
 
-terminal
domain and causes Rho activation. Moreover, constitu-
tively active Q63L RhoA is selectively localized in the rear
part of the cells. Thus, phosphorylated ERM has a potential
function in establishing plasma membrane “posteriority”
in the induction of the uropod in T lymphocytes.
 
Introduction
 
To defend our bodies against invasive pathogens, immune cells
such as leukocytes and lymphocytes quickly migrate toward
sites of infection or toward appropriate anatomical compart-
ments (Springer, 1994; Kunkel and Butcher, 2002; Hogg et al.,
2003). For achieving this migration, immune cells are intrinsically
equipped with specialized abilities. One of these is the ability
to sense “directional cues” that inform them about the specific
sites to be mobilized. Various receptors for chemoattractants
and adhesion molecules are responsible for this (Springer,
1994; Kunkel and Butcher, 2002; Hogg et al., 2003). Another
contributing ability is the much higher motility of immune cells
compared with the cells in the vast majority of tissues. Several
factors are considered to cause this high motility, including (1)
relatively low adhesiveness, (2) capacity for rapid cytoskeletal
reorganization, and (3) definite asymmetry of cellular components
along the front–rear axis that is used for effective directional
movement. At the front part of the cell (the leading edge), effi-
cient dynamics of actin cytoskeleton organization contribute to
pulling the cell body upward in the direction of a chemoattractive
gradient (Sánchez-Madrid and del Pozo, 1999; Hogg et al., 2003).
Detachment from the substratum and quick retraction at the
rear part of the cell (the trailing edge) also facilitate the rapid
migration (Sánchez-Madrid and del Pozo, 1999; Hogg et al.,
2003). However, the underlying mechanisms by which lympho-
cytes achieve clear cell polarity remain poorly understood.
Migrating lymphocytes possess a unique cellular structure
called the uropod, a spherical membrane protrusion budding
from the rear part of the cell body (Sánchez-Madrid and del
Pozo, 1999). The roles of the uropod in lymphocyte migration,
as well as the molecular mechanisms organizing this structure,
are largely unknown. The finding that several molecules are
selectively compartmentalized at the uropod provides some clues
to clarify these subjects. For instance, some transmembrane
adhesion molecules, including CD43, CD44, intercellular
adhesion molecules, and PSGL-1, are concentrated at the uropod
(Sánchez-Madrid and del Pozo, 1999). These molecules have a
motif that can bind ezrin/radixin/moesin (ERM) proteins at the
intracellular part; therefore, it is reasonable to suggest that the
ERM proteins are also accumulated in the uropod (Mangeat et
al., 1999; Sánchez-Madrid and del Pozo, 1999; Tsukita and
Yonemura, 1999; Bretscher et al., 2002). ERM proteins act as
membrane–cytoskeleton linkers by binding to the membrane
proteins at their NH
 
2
 
-terminal (NT) domains and to F-actin at
its COOH-terminal (CT) domain (Mangeat et al., 1999; Tsukita
and Yonemura, 1999; Gautreau et al., 2000; Bretscher et al.,
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2002). The linker function is regulated by the phosphorylation
of a conserved threonine residue in the CT domain of each
ERM protein. This Thr phosphorylation disrupts the intramo-
lecular interaction between the NT and CT domains, allowing
them to bind to membrane proteins and F-actin. However, the
roles of ERM proteins and Thr phosphorylation in uropod for-
mation or lymphocyte polarity remain to be elucidated.
In this study, by using a T lymphoma cell line, EL4.G8,
that constitutively possesses a clear uropod, we show potential
roles of the phosphorylated ERM (p-ERM) proteins not only in
uropod formation but also in cell polarization in cooperation
with Rho–ROCK signaling.
 
Results
 
Uropod formation in EL4.G8 cells 
requires Ser/Thr kinase activity and 
actin cytoskeleton
 
In general, the uropod is induced in a chemoattractant- or
adhesion-dependent fashion (Sánchez-Madrid and del Pozo,
1999); thus, it seems relatively unstable. We took advantage
of the mouse T lymphoma cell line EL4, a well-known cell
line that is often used for investigating T cell functions, be-
cause it spontaneously constructs a uropod when grown in
nonadhesive culture dishes and is therefore suitable for uro-
pod studies. To obtain cells with clearer and more frequent
uropod formation, we isolated a subclone, G8, with these fea-
tures (
 
 
 
80% of the G8 cells construct a uropod) from the pa-
rental line by limiting dilution (Fig. 1 A, arrows). EL4.G8
cells exhibited a hand mirror–shaped morphology, with a nar-
row neck segregating the cell body from the spherical uropod
protrusion. We often observed that these cells attached to
each other by their uropods to form aggregates, an observa-
tion that indicated that this structure is somewhat stickier than
other parts of the cell (Fig. 1 A, right). Confocal microscopic
analysis clearly demonstrated that transmembrane proteins
such as CD44 and CD43 were selectively localized at the pro-
truding part (Fig. 1, B and C). In addition, ezrin, one of the
ERM proteins, also accumulated in this part (Fig. 1 B). A
polyclonal antibody that recognizes the phosphorylated CT
Thr residues of all three ERM proteins clearly stained the pro-
truding structure (Fig. 1, C and D), suggesting that the ezrin
accumulated in this compartment is the Thr567-phosphory-
lated form. In contrast, a large fraction of F-actin is accumu-
lated at the cell margin opposite to the protruding structure;
thus, this part is likely the leading edge, although a faint sig-
nal for actin filaments was also detected at the uropod protru-
sion (Fig. 1 D). A leukocyte integrin, LFA-1 (
 
 
 
L
 
 
 
2), was
also enriched in the leading edge (Fig. 1 E). Therefore,
EL4.G8 cells show typical features of lymphocyte polariza-
tion (Sánchez-Madrid and del Pozo, 1999).
When EL4.G8 cells were treated with a broad-spectrum
Ser/Thr kinase inhibitor, staurosporine, uropod protrusion was
completely abolished, as was p-ERM staining, resulting in uni-
form CD44 distribution on the plasma membrane (Fig. 1 F). In
accordance with this observation, staurosporine abolished the
phosphorylation of all ERM proteins and the association be-
tween ezrin and CD44 (Fig. 1 G). An actin polymerization in-
hibitor, cytochalasin D, also disrupted the uropod and brought
about uniform p-ERM and CD44 distributions (Fig. 1 F).
Therefore, Ser/Thr kinase activity and the actin cytoskeleton
are both required for maintenance of the uropod in EL4.G8
cells, and ezrin functions appear to be under the control of
these cellular processes.
 
The role of Thr567 phosphorylation in 
the uropod localization of ezrin
 
To address the details of ezrin localization in the uropod, we
transfected plasmids expressing various GFP-tagged mutant
forms of ezrin into EL4.G8 cells and obtained multiple stable
lines (Fig. 2, A and D). Transfection with the control vector
expressing GFP resulted in cytoplasmic and nuclear distribu-
tion of this reporter protein (Fig. 2, B and C). In contrast,
wild-type (WT) ezrin-GFP was preferentially localized at the
peripheral membrane, especially in the uropod rather than the
cell body, although a weak signal was also detected in the cy-
toplasm. A mutant ezrin in which the CT Thr was replaced by
Ala (T567A) was distributed diffusely in the cytoplasm. This
mutant cannot be phosphorylated at this residue and, there-
fore, does not undergo the intramolecular NT and CT domain
Figure 1. EL4.G8 cells show polarized morphology with a clear uropod
that is regulated by Ser/Thr kinases and the actin cytoskeleton. (A) Phase-
contrast view showing the hand mirror–shaped morphology of EL4.G8
cells with clear uropods (left, arrows). Aggregation of EL4.G8 cells by
their uropods (left). (B–E) Selective localization of the uropod markers
(CD44 and CD43) and p-ERM in the EL4.G8 cell uropod, whereas F-actin
and LFA-1 are enriched in the leading edge. Fixed, permeabilized cells
were stained with fluorescence-labeled probes for cell surface CD44,
CD43, or LFA-1, and for intracellular ezrin, p-ERM, or F-actin. (F) Stauro-
sporine and cytochalasin D disrupt uropod structure. Cells were treated
with DMSO (cont.), staurosporine (stauro.), or cytochalasin D (cyt.D) and
stained for p-ERM and CD44. (G) Staurosporine abolishes ERM phosphor-
ylation and the interaction between CD44 and ezrin in EL4.G8 cells. The
total amount of ezrin and the p-ERM level were determined by Western
blotting using lysates from control or staurosporine-treated cells (top and
middle). CD44 ezrin interaction was detected by the immunoprecipitation
of CD44 and Western blotting for ezrin (bottom). Bars (A–F), 10  m. 
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dissociation and mimics the dormant form of ezrin (Gautreau
et al., 2000; Coscoy et al., 2002). In marked contrast, another
mutant with replacement of this Thr by Asp, T567D, which
does not undergo NT and CT domain association and thus
mimics the phosphorylated active form with membrane–cyto-
skeleton linker activity (Gautreau et al., 2000; Coscoy et al.,
2002), exclusively accumulated in the uropod colocalized
with CD44 (Fig. 2 B, asterisks). The fluorescent signal of the
NT domain fragment tagged with GFP was also detected at
the uropod, as well as at the peripheral membrane of the cell
body, confirming the requirement of the NT domain for ezrin
to localize in the uropod. In contrast, the CT domain fragment
of ezrin was accumulated at the leading edge and was well-
colocalized with F-actin, but was not abundant in the uropod,
indicating that this fragment freely associates with the actin
cytoskeleton. Such intracellular localization patterns of ezrin
mutants were also observed in another T cell lymphoma line,
BW5147, although the cells bearing a uropod in this line are a
minor population and the sizes of the uropods are much
smaller than in EL4.G8 cells (unpublished data).
Consistent with the observation of colocalization with
CD44 in the uropod, associations between CD44 and WT,
T567D, or NT ezrin were readily detected by immunoprecip-
itation with anti-CD44 antibody followed by Western blot-
ting with anti-GFP antibody, whereas those between CD44
and T567A or CT ezrin were undetectable (Fig. 2 E). These
findings suggest that Thr567 phosphorylation, and the conse-
quent conformational changes of ezrin, anchor this protein in
the uropod.
 
T567D ezrin enhances uropod size
 
The size of the uropod was markedly enhanced by T567D
ezrin, whereas T567A ezrin had little effect on it (Fig. 2 F).
Forced expression of WT ezrin only slightly augmented the
uropod’s size, suggesting that the total capacity for ERM Thr
phosphorylation is limited in each cell and that a fraction of
ezrin-GFP proteins is incorporated into the uropod mem-
brane. Because NT ezrin transfectants showed a slight dimin-
ishment of the incidence of cells carrying the uropod (64%
for NT, compared with 82% for the vector or WT) and of the
uropod’s size (Fig. 2 F), this type of deletion mutant might
function in a weakly dominant-negative fashion. Interest-
ingly, F-actin was apparently accumulated at the enlarged
uropod in T567D ezrin transfectants, demonstrating that the
activated ezrin facilitates the organization of the cortical actin
cytoskeleton underneath the uropod membrane (Fig. 2 C, ar-
rows). Thus, Thr567 phosphorylation of ezrin can influence
the integrity of the uropod in T lymphocytes.
Figure 2. Intracellular localization of ezrin
mutants and the enhancement of uropod size
in T567D ezrin transfectants. (A) GFP-tagged
ezrin constructs used in this study. In point
mutant constructs T567A or T567D, a CT
phosphorylation site, Thr567 (T) was replaced
by Ala (A) or Asp (D), respectively. (B and C)
Intracellular localization of ezrin mutants in
EL4.G8 cells. Stable transfectants were exam-
ined for the localization of GFP as well as
CD44 (B) or F-actin (C). Each set of panels
corresponds to the construct shown to the left
in A. T567D ezrin was exclusively localized at
the uropod (asterisks) and colocalized with the
enhanced F-actin signal (C, arrows). Bar, 10
 m. (D) GFP-tagged proteins expressed in
stable transfectants were detected by Western
blotting using antiezrin or anti-GFP antibody.
Polyclonal antiezrin antibody recognizes an
epitope in the CT domain and, thus, does not
detect the NT fragment. The arrowhead indi-
cates endogenous ezrin. (E) Interaction between
CD44 and ezrin mutants was detected by the
immunoprecipitation of CD44 and Western
blotting for GFP. (F) T567D ezrin increases
uropod length. The length of the uropod was
measured and expressed as mean   SD (n  
200). Each bar represents an individual stable
clone of a different type of ezrin transfectant. 
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T567D ezrin induces construction of a 
plasma membrane polar cap in uropod-
less situations
 
As expected, staurosporine treatment disrupted the uropod as
well as the polarized distributions of GFP signal and CD44 in
WT ezrin transfectants (Fig. 3 A). Surprisingly, in T567D ezrin
transfectants, despite the fact that the typical uropod also disap-
peared upon treatment with staurosporine, the GFP signal and
CD44 clearly accumulated at one pole of the cells to form a
capped structure (Fig. 3, A [arrows] and B). A similar cap
structure was constructed in BW5147 cells transfected with
T567D ezrin and treated with staurosporine (unpublished data).
These findings strongly suggest that the T567D ezrin can pre-
serve the plasma membrane polarity even in the uropod-abol-
ished cells. Because polar cap formation was not observed in
NT ezrin transfectants, this phenomenon requires the phos-
phorylated CT domain. In addition, cytochalasin D canceled
the induction of polar cap formation by T567D ezrin (Fig. 3, A
and B), suggesting that F-actin is also required for this event.
To further address the importance of the actin cytoskele-
ton in polar cap formation, we constructed a variant form of
T567D ezrin that has a 6-aa deletion at the CT end and lacks
actin-binding ability (T567D-
 
 
 
AB; Turunen et al., 1994).
Comparing T567D with T567D-
 
 
 
AB in transient transfection
followed by staurosporine treatment, it is apparent that T567D-
 
 
 
AB was unable to construct the polar caps in EL4.G8 cells
(Fig. 3, C and D). As the deletion of the CT six amino acids is a
minimal alteration except for its effect on actin-binding ability,
T567D-
 
 
 
AB is thought to preserve most other functions of ac-
tivated ezrin. Therefore, this finding suggests that polar cap
formation is dependent on actin-binding ability as well as on
membrane anchorage of phosphorylated ezrin, but independent
of other interactive partners.
To confirm the ability of T567D ezrin to induce the polar
cap in naturally unpolarized cells, we transfected the construct
into the myeloma cell line X63.653, which does not carry a
uropod or show specific CD44 (Fig. 3 E) and F-actin localiza-
tion (not depicted). Strikingly, T567D ezrin induced the con-
struction of the polar cap accompanied by CD44 accumulation
in these cells, although the uropod was not induced, whereas
WT, NT, or T567D-
 
 
 
AB ezrin had no influence on CD44 lo-
calization (Fig. 3, E [arrows] and F). These results indicate that
X63.653 cells seem to be inactive in the machinery not only for
ezrin phosphorylation but also for uropod protrusion, and,
hence, T567D ezrin induces only plasma membrane polar-
ization in these cells. Together, these findings suggest that
Thr567-phosphorylated ezrin has the ability to organize the
plasma membrane polarity in several uropod-less situations,
whereas uropod protrusion requires an additional mechanism.
 
Rho–ROCK signaling is required for 
uropod protrusion, but not for polar cap 
formation
 
Because several Ser/Thr kinases (including the Rho effector
ROCK and PKCs) have been shown to phosphorylate ERM
proteins (Mangeat et al., 1999; Tsukita and Yonemura, 1999;
Bretscher et al., 2002), we next treated EL4.G8 cells with an
inhibitor for ROCK (Y-27632) or for PKCs (bisindolylmaleim-
ide I [BIM]). BIM had no remarkable effect on the morphology
of the cells (not depicted). In contrast, Y-27632 completely
Figure 3. T567D ezrin induces a plasma
membrane polar cap in uropod-less cells.
(A) T567D ezrin can cause formation of the
polar cap in staurosporine-treated (arrows) but
not in cytochalasin D–treated EL4.G8 cells.
WT, T567D, and NT ezrin transfectants were
treated with inhibitors and stained for CD44.
Bar, 10  m. (B) Percentage of cells exhibiting
the polar cap in A (n   130). (C) T567D- AB
ezrin lacks the ability to induce polar cap for-
mation in staurosporine-treated EL4.G8 cells.
Cells were transiently transfected with con-
structs for T567D or T567D- AB ezrin, and
after 24 h the cells were treated with stauro-
sporine and stained for CD44. In contrast with
the results for T567D- AB, clear polar caps
are observed in T567D ezrin–transfected cells
(arrows). Bar, 10  m. (D) Percentage of cells
exhibiting the polar cap in C (n   130). (E)
T567D ezrin can induce organization of the
polar cap in X63.653 myeloma cells (arrows),
which are naturally unpolarized with regard
to the plasma membrane. X63.653 cells were
transiently transfected with constructs for WT,
T567D, NT, or T567D- AB ezrin and stained
for CD44 24 h after the transfection. Bar, 10
 m. (F) Percentage of cells exhibiting the
polar cap in C (n   120). 
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eliminated the uropod, although the CD44/p-ERM polar cap
was maintained (Fig. 4, A and B). The preservation of p-ERM
was confirmed by Western blotting (Fig. 4 C). The phosphory-
lation status was also unchanged in Y-27632–treated BW5147
cells, despite the fact that the uropod was completely disrupted
(unpublished data). These experiments demonstrate that endog-
enous p-ERM proteins are also capable of constructing the po-
lar cap in uropod-less cells. Likewise, transfectants of WT as
well as T567D ezrin exhibited a polar cap but not a uropod un-
der the ROCK-inhibited condition (Fig. 4, A and B). Thus,
ERM phosphorylation is independent of ROCK as well as of
PKCs in EL4.G8, but ROCK activity is indispensable for the
formation of the mature uropod.
Next, we performed transient expression of RhoA mu-
tants tagged with GFP (Subauste et al., 2000) in EL4.G8 cells.
WT RhoA showed only a diffuse distribution in the cytoplasm,
including the leading edge, without affecting uropod formation
(Fig. 4, D and E). In contrast, a constitutively active RhoA
(Q63L) was selectively accumulated in the rear part of EL4.G8
cells, including the uropod (Fig. 4, D and E). This suggests that
activated Rho and likely the downstream ROCK activation are
spatially restricted to this part. On the other hand, forced ex-
pression of a dominant-negative mutant of RhoA, T19N, re-
markably suppressed uropod formation (Fig. 4, D and E).
Among the uropod-less cells, however, the majority (71%) re-
tained the polar cap, further supporting the notion that the for-
mation of the protrusive uropod requires Rho–ROCK activ-
ity, although the p-ERM–mediated construction of the plasma
membrane polarity is independent of this pathway.
 
Phosphorylated ezrin interacts with Dbl 
and induces Rho activation
 
To address the possibility that p-ERM is involved in Rho–
ROCK signaling, we checked the level of Rho-GDP/GTP ex-
change activity associated with p-ERM in EL4.G8 cells. Using
immunoprecipitated p-ERM protein complex from the cell ly-
sate, the exchange activity was assessed by an in vitro nucle-
otide exchange reaction for recombinant Rho-GDP, followed
by RBD (Rho-binding domain)-GST–mediated pull-down de-
tection of Rho-GTP. Strikingly, we detected a substantial
nucleotide exchange activity for Rho in p-ERM–containing
precipitate, whereas no activity was detected using control anti-
body (Fig. 5 A). When p-ERM was depleted previously from
the cell lysate, the exchange activity associated with ezrin was
markedly reduced (Fig. 5 D).
The activation of Rho is known to be mediated by various
guanine nucleotide exchange factors (GEFs; Schmidt and Hall,
2002), raising the possibility that ezrin could elicit its exchange
activity by binding to some GEFs. Thus, we next searched for
Rho-GEFs associated with ezrin. One of them, Dbl, was copre-
cipitated with ezrin from EL4.G8 cell lysate (Fig. 5 B). Similar
experiments were also performed using various transfectants
for ezrin mutants by immunoprecipitation using anti-GFP anti-
body. Interestingly, the binding of Dbl to T567D ezrin was
markedly augmented compared with its binding to WT ezrin,
whereas only a faint Dbl signal was detected in the T567A mu-
tant, suggesting that Dbl is able to associate selectively with ac-
tivated ezrin (Fig. 5 C). Dbl was coprecipitated with the NT
fragment of ezrin but not with the CT fragment (Fig. 5 C), indi-
cating that ezrin binds to Dbl by its NT domain. The level of
Rho-GEF activity associated with ezrin mutants was correlated
with the Dbl interaction (Fig. 5 F). Moreover, depletion of Dbl
from EL4.G8 cell lysate, followed by the precipitation of ezrin,
markedly diminished the GEF activity (Fig. 5 E), indicating
that a large fraction of the association of GEF activity with
ezrin is likely mediated by Dbl.
To determine whether Dbl is involved in uropod forma-
tion in vivo, we transfected Dbl-AID, a construct for the GFP-
tagged autoinhibitory domain (AID) of Dbl that potentially in-
terferes with the GEF activity mediated by Dbl (Bi et al.,
2001), into EL4.G8 cells. Compared with the results of control
experiments, the percentage of cells exhibiting the uropod in
the Dbl-AID–expressing cells was significantly decreased (Fig.
5 G), suggesting that Dbl plays a substantial role in uropod for-
mation. However, because the inhibitory effect of Dbl-AID is
insufficient, it is suggested that the dominant-negative action of
Figure 4. The Rho–ROCK pathway is involved in uropod formation.
(A) Y-27632 abolishes uropod but not polar cap formation (arrows).
Y-27632–treated parental EL4.G8 cells were stained for p-ERM and
CD44 (top panels). GFP-tagged WT and T567D ezrin were also colocal-
ized with CD44 in Y-27632–treated stable transfectants (middle and
bottom panels). Bar, 10  m. (B) Percentage of cells exhibiting the polar
cap in A (n   150). (C) Y-27632 does not alter the phosphorylation sta-
tus of ERM proteins. The total amount of ezrin and the p-ERM level were
determined by Western blotting using lysates from control or Y-27632–
treated EL4.G8 cells. (D) WT RhoA shows a diffuse distribution in the
cytoplasm, including the leading edge (arrowhead). Constitutively active
(Q63L) RhoA is preferentially localized at the rear part of the cells (asterisk),
and a dominant-negative form (T19N) abolishes uropod formation but
not polar cap formation (arrow). EL4.G8 cells were transiently trans-
fected with WT, Q63L, or T19N RhoA and examined for GFP and CD44
24 h after the transfection. Bar, 10  m. (E) Percentage of cells exhibiting
the uropod in D (n   75). 
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this artificial protein fragment might be limited in vivo, or that
the other GEFs might associate with p-ERM (Fig. 5, compare
the residual GEF activity in E with that in D). Together, these
results suggest that phosphorylated open-form ezrin, but not
the latent form, potentially functions as an upstream regulator
for Rho activation and uropod formation, through its binding to
Dbl in EL4.G8 cells.
 
A polar cap is constructed over the 
posterior cytoplasm
 
It is well-established that migrating lymphocytes exhibit
unique intracellular polarity, i.e., that the microtubule organiz-
ing center (MTOC) and the Golgi apparatus are arranged in the
posterior part behind the nucleus, thus revealing a cytoplasmic
front–rear axis (Sánchez-Madrid and del Pozo, 1999). MTOC
positioning in EL4.G8 cells was rather flexible: 70.5% of cells
showed the rear MTOC, whereas in some cells, the MTOC was
positioned clearly in the front cytoplasm, near the leading edge
(Fig. 6 A). The Golgi apparatus was located in the middle or
front part of the cell (in 72.6% of cells; Fig. 6 A), as was re-
vealed by staining with anti-GM130 antibody. These unstable
locations of the MTOC or the Golgi apparatus might be caused
by the rapid cell cycle in this cell line. Ceramide analogues
have been reported to label the Golgi apparatus (Pagano et
al., 1991). However, fluorescence-labeled C
 
5
 
-ceramide clearly
stained the cytoplasmic components in the rear part of the cell
body and the uropod, in addition to the Golgi apparatus, in
EL4.G8 cells (Fig. 6 A). In comparison to the MTOC or Golgi
positioning, the intracellular arrangement of the front nucleus
and the C
 
5
 
-ceramide–labeled rear cytoplasm was obviously sta-
ble (93.3% of cells showed this pattern). A similar staining pat-
tern was observed in BW5147 cells bearing a uropod, although
the MTOC and the Golgi apparatus in these cells were mostly
detected in the rear cytoplasm (
 
 
 
95%; unpublished data).
Thus, C
 
5
 
-ceramide was considered to be a useful probe for vi-
sualizing the posterior cytoplasm in EL4.G8 cells. Therefore,
although they exhibit a slightly different feature of cell polarity
from that observed in migrating lymphocytes, EL4.G8 cells
show a unique asymmetry along the front–rear axis (Fig. 6 E).
Interestingly, in Y-27632–treated cells, the CD44-associ-
ated polar cap covered the posterior cytoplasm (Fig. 6 B, ar-
rows), indicating that the plasma membrane polarization in-
duced by p-ERM is aligned with the cytoplasmic polarity axis.
A similar pattern was observed in Y-27632–treated WT or
T567D ezrin transfectants, and in staurosporine-treated T567D
ezrin transfectants (Fig. 6 C). Because the treatment with stau-
rosporine induced a disorganized and fragmented posterior cy-
toplasm, maintenance of this structure seems to require proper
kinase activity. Next, we obtained cells stably transfected with
GFP-tagged WT or Q63L RhoA for further analysis. We con-
firmed that the Q63L RhoA was localized in the rear cyto-
plasm, whereas WT RhoA was distributed diffusely in the cy-
toplasm, including the leading edge (Fig. 6 D). As expected,
when these cells were treated with Y-27632, the polar cap was
apparently correlated with the GFP-Q63L RhoA location. We
further obtained stable T567D ezrin transfectants in X63.653
cells, and again observed the polar cap located over the poste-
rior cytoplasm containing the T567D ezrin (Fig. 6 F). Together,
these findings suggest that p-ERM has an ability to adapt the
plasma membrane polarity, which is established on its own, to
the posterior pole of the cytoplasm.
 
T567D ezrin augments cell migration
 
In general, the uropod is observed during lymphocyte migra-
tion (Sánchez-Madrid and del Pozo, 1999), suggesting that this
Figure 5. Rho-GEF activity associated with p-ERM and interaction of Dbl
and open-form ezrin in EL4.G8 cells. (A) Protein complex containing p-ERM
has Rho-GEF activity. p-ERM was immunoprecipitated from EL4.G8 cell
lysate, and the associated Rho-GEF activity was measured compared with
that when the immunoprecipitation was performed with control antibody.
Rho-GTP in the reaction was pulled down and detected by Western blot-
ting (top). The presence of p-ERM was also confirmed by Western blotting
(bottom). (B) Ezrin interacts with Dbl. Dbl coimmunoprecipitated with ezrin
was detected by Western blotting. (C) Open-form ezrin specifically binds
to Dbl by its NT domain. Ezrin mutants were immunoprecipitated with anti-
GFP antibody from lysates of stable transfectants and the interaction with
Dbl was analyzed. (D) Most of the Rho-GEF activity associated with ezrin
is associated with the phosphorylated form. p-ERM was immunodepleted
from EL4.G8 cell lysate, and Rho-GEF activity associated with ezrin was
measured compared with that when the immunodepletion was performed
with control antibody. (D and E) The relative activity compared with the
control level was normalized by the amount of immunoprecipitated ezrin
and is shown as a percent of control (histograms). (E) Dbl mediates a major
part of the association of Rho-GEF activity with ezrin. Dbl was immuno-
depleted and Rho-GEF activity associated with ezrin was analyzed. (F)
Rho-GEF activity is increased in lysates containing T567D compared with
WT ezrin and the activity is associated with the NT but not the CT domain.
Rho-GEF activity was analyzed in lysates containing ezrin mutants. The
activity in lysates containing T567D relative to that in lysates containing
WT ezrin is shown (histogram). (G) Overexpression of Dbl-AID significantly
inhibits uropod formation in EL4.G8 cells. EL4.G8 cells were transiently
transfected with a construct for GFP-tagged Dbl-AID, and the percentage
of cells exhibiting the uropod is shown (n   180). 
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structure might be important for efficient lymphocyte motility.
EL4.G8 cells exhibited clear chemotactic migration toward a
chemokine, stromal cell–derived factor-1 (SDF-1), and this
chemotaxis was prevented by pertussis toxin, which inactivates
G
 
 
 
i-coupled chemokine receptor signaling, as well as by stau-
rosporine and cytochalasin D (Fig. 7 A). Y-27632 also inhib-
ited the chemotaxis, although withdrawal of the drug restored
the activity (Fig. 7 B), indicating that the effects of Y-27632
are reversible. Therefore, ROCK activity is required for the
proper chemotactic migration of EL4.G8 cells. Interestingly,
among the transfectants of various ezrin mutants, only T567D
ezrin transfectants showed higher chemotactic activity toward
SDF-1, whereas other transfectants had activity comparable to
that of the control cells (Fig. 7 C). We confirmed similar
enhancement of chemotaxis in other transfectant clones for
T567D ezrin. Together, these findings support the notion that
ezrin phosphorylation and Rho–ROCK signaling regulate the
efficiency of lymphocyte migration.
 
Discussion
 
In this study, chiefly using EL4.G8 cells, we showed that the
preferential localization of an ERM protein, ezrin, in the uro-
pod requires Thr567 phosphorylation, and that a phosphoryla-
tion-mimetic form, T567D ezrin, induces various cellular
phenomena, including enhancement of uropod integrity, aug-
mentation of chemotaxis, and polar cap formation. Our find-
ings support the notion that p-ERM proteins are crucial compo-
nents of lymphocyte morphology and motility. Moreover, we
suggest that there is a functional link between the p-ERM–
mediated structural framework of the plasma membrane and
Rho–ROCK signaling underneath the plasma membrane of the
uropod. Uropod protrusion in EL4.G8 cells depends on Rho
and ROCK activity. Not only the uropod, but also the p-ERM–
associated polar cap, clearly overlaid the rear part of the cyto-
plasm, in which active Rho is concentrated. Such correlation
between specific plasma membrane and cytoplasmic compo-
Figure 6. A polar cap covers the posterior
part of the cell. (A) EL4.G8 cells exhibit a
unique cytoplasmic polarity. EL4.G8 cells
were stained for CD44 and  -tubulin, F-actin
and  -tubulin,  -tubulin and the posterior cyto-
plasm (C5-ceramide), or GM130 and the poste-
rior cytoplasm (C5-ceramide). Arrowheads and
an arrow indicate the positions of the MTOC
and the Golgi apparatus, respectively, in each
cell. (B) The polar cap is constructed over
the posterior part of the cytoplasm (arrows).
Y-27632– or staurosporine-treated EL4.G8
cells were stained for CD44 and the posterior
cytoplasm. Composite images for  -tubulin/
CD44/nucleus are shown (right) together with
the MTOC position (arrowheads). (C) The
T567D ezrin–associated polar cap covers the
posterior cytoplasm in Y-27632– or staurospo-
rine-treated transfectants (arrows). A similar
situation is observed in Y-27632 but not in
staurosporine treatment in WT ezrin transfec-
tants (arrows). (D) WT and Q63L RhoA show
different intracellular localization in the stable
transfectants. WT RhoA is distributed diffusely in
the cytoplasm, including the leading edge
(arrowheads), whereas Q63L RhoA is local-
ized in the posterior cytoplasm beneath the
uropod, or beneath the polar cap when the
transfectant is treated with Y-27632 (arrows).
Similar but less clear localization of WT RhoA
in the posterior cytoplasm is also observed in
Y-27632-treated WT RhoA transfectants (ar-
rows). (E) Schematic representation of a typical
arrangement of cellular structures in an EL4.G8
cell. (F) The T567D ezrin–associated polar cap
covers the posterior cytoplasm in X63.653
cells (arrows). Bars (A–D and F), 10  m. 
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nents might stabilize the “posteriority,” and consequently es-
tablish a firm front–rear polarity axis, of the cell.
The formation of the polar cap seems to depend on both
membrane anchorage and actin binding induced by CT phos-
phorylation of ERM proteins, but not on other interactive part-
ners. It could be hypothesized that F-actin gathers multiple
p-ERM molecules to “cross-link” them at one place underneath
the plasma membrane. Under normal conditions, the p-ERM
cap structure is likely to be reinforced by further construction
of a kind of mature “uropod scaffold” that is mediated by other
cellular components but sensitive to staurosporine. This seems
reasonable, because even the ezrin mutants lacking actin-bind-
ing ability (such as NT and T567D-
 
 
 
AB) are able to localize in
the uropod, probably by the free NT domain, whereas stauro-
sporine prevents this localization.
ERM proteins have been suggested to participate in Rho
activation (Mackay et al., 1997; Sasaki and Takai, 1998; Tsu-
kita and Yonemura, 1999). In vitro interaction of radixin and
Dbl was previously reported (Takahashi et al., 1998). In this
study, we showed that the protein complex containing phos-
phorylated ezrin exhibits Rho-GDP/GTP exchange activity,
and that only the open-form ezrin can associate with Dbl
through its NT domain. These findings suggest that accumula-
tion of p-ERM is likely to augment the local activation of Rho
beneath the uropod membrane. The overexpression of Dbl-AID
reduced the ability of uropod formation in EL4.G8 cells, indi-
cating that Dbl plays a substantial role in vivo. However, be-
cause various pathways can potentially induce Rho activation
(Bishop and Hall, 2000; Ridley, 2001), it is also possible that
Rho might be activated independently of ERM. The p-ERM–
Dbl complex might be important for the maintenance of Rho
activity restricted in the uropod membrane. There is a contro-
versy concerning ROCK as a kinase for the CT Thr residues of
ERM proteins, and this function has been suggested to depend
on the cell type (Matsui et al., 1999; Yonemura et al., 2002). At
least in EL4.G8 cells, ROCK is not responsible for ERM phos-
phorylation. In addition, though we treated EL4.G8 cells with a
variety of chemical inhibitors for PKCs (BIM and Gö6976),
PKA (KT5720), MEK (PD98059), p38MAPK (SB203580), or
MLCK (ML-7), these drugs had no remarkable effect on the
morphology of the cells. Thus, what maintains the p-ERM fol-
lowed by the posterior Rho–ROCK signaling for uropod for-
mation in EL4.G8 cells remains undetermined at this time.
The triggering of lymphocyte migration by various at-
tractants involves complicated signaling (Ward et al., 1998;
Hogg et al., 2003), although the overall picture of it remains in-
complete. Environmental directional cues are thought to trigger
the sequential signaling events upstream of the ERM phosphor-
ylation, as well as the Rho–ROCK pathway, in unpolarized
lymphocytes, and to induce the polarized morphology of lym-
phocytes that are able to migrate efficiently (Fig. 8). Our obser-
vations suggest that this process can be dissected into two
steps: p-ERM–mediated plasma membrane polarization and
Rho–ROCK-mediated uropod protrusion (Fig. 8). In future
studies, it will be important to identify any kinases that phos-
phorylate ERM CT Thr residues, to link the upstream signaling
with p-ERM during lymphocyte migration.
In some situations, the uropod of lymphocytes becomes a
“sticky” part (Sánchez-Madrid and del Pozo, 1999). This might
be because several kinds of adhesion molecules are collected at
this part, whereas rapidly regulatable adhesion components,
such as integrins, are placed on the leading edge and cell body.
In addition, higher membrane–cytoskeleton linking activity by
p-ERM proteins likely reduces the local deformability of the
plasma membrane. We think that both factors may reduce the
rapid motility of the cell. Therefore, uropod formation, by
which the relatively sticky and rigid cellular components are
restricted to the posterior part, is beneficial for high-speed mi-
gration in lymphocytes.
In addition, the uropod may function in effective tail re-
traction by concentrating the contraction machinery in the rear
part of the cell. The Rho–ROCK pathway is known to be in-
volved in a broad spectrum of cell contraction phenomena
(Bishop and Hall, 2000; Ridley, 2001). The retraction of the
trailing edge has been demonstrated to require this pathway in
migrating leukocytes (Alblas et al., 2001; Worthylake et al.,
2001; Smith et al., 2003), suggesting that these proteins are
crucial for the maintenance of the posterior structure. Recently,
it has been shown that the “backness” signal is generated by the
Figure 7. Chemotactic migration of EL4.G8 cells toward SDF-1 and
augmentation of the activity in T567D ezrin transfectants. Chemotactic
activity was determined by constant-period counting using a flow cytome-
ter and is shown as mean   SD (A–C). (A) EL4.G8 cells exhibit typical
chemotaxis toward SDF-1 (10 ng/ml), and this chemotaxis is markedly
inhibited by pretreatment of the cells with pertussis toxin (PTx), staurosporine,
or cytochalasin D. (B) EL4.G8 cell chemotaxis is dependent on ROCK
activity. Cells were pretreated with Y-27632 and the chemotaxis assay
was performed in medium containing the drug (in) or in medium only
(wash out [w/o]). (C) T567D ezrin enhances chemotaxis. Transfectants
preincubated with or without PTx were examined by the chemotaxis assay.
Numbers represent the fold increase of chemotaxis toward SDF-1 (specific
activity) compared with that of cells incubated in medium alone. A result
typical of at least three experiments is shown. 
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activation of Rho by chemoattractant receptors in neutrophils
(Meili and Firtel, 2003; Xu et al., 2003). In EL4.G8 cells, we
show that Q63L RhoA, which is constitutively active indepen-
dent of GEFs, is accumulated in the posterior cytoplasm. Be-
cause no association between ezrin and Rho could be detected
(unpublished data), it can be postulated that there is some
mechanism by which Rho-GTP is selectively anchored in the
rear part of the cell, which is independent of p-ERM/Dbl func-
tion, or actively excluded from the leading edge.
Several reports have shown that Y-27632 induces a long
tail that remains behind the cells because of blockage of the
posterior retraction (Worthylake et al., 2001; Smith et al., 2003;
Xu et al., 2003). However, the requirement of Rho–ROCK sig-
naling for the uropod protrusion in the EL4.G8 model, as re-
vealed by the ability of Y-27632 and dominant-negative Rho to
completely abolish the uropod, seems to contradict the idea that
the major function of this pathway is only for contraction. The
uropod is usually observed as a membrane protrusion lifted off
from, rather than attached to, the substratum in lymphocytes
(Sánchez-Madrid and del Pozo, 1999). These facts indicate that
the uropod, at least in lymphocytes, is not a simple tailing
structure but rather is an active machinery for efficient contrac-
tion accompanied by somewhat of a protrusive effect, and thus
is basically different from the trailing edges observed in adher-
ent cells such as fibroblasts and epithelial cells.
A curious point is that the cytoplasmic polarity (i.e., the
intracellular arrangement) of the nucleus, the MTOC, and the
Golgi apparatus that is observed in migrating lymphocytes is,
in general, in the opposite direction from that observed in many
types of adherent cells with migrating morphology. In fibro-
blasts and astrocytes, the MTOC and the Golgi apparatus are
positioned on the leading edge side, relative to the nucleus,
during migration (Etienne-Manneville and Hall, 2002; Fukata
et al., 2003). This suggests that the construction of the cell po-
larity in lymphocytes may follow different rules from those fol-
lowed in adherent cells. Furthermore, although p-ERM is
generally localized in an actin-rich compartment of the cell
(Mangeat et al., 1999; Tsukita and Yonemura, 1999; Bretscher
et al., 2002), it is rather excluded from the actin-rich leading
edge of migrating lymphocytes. It is likely that p-ERM–spe-
cific anchoring components exist in the posterior compartment
in lymphocytes.
ERM proteins are involved in the integrity of the mi-
crovilli that constitute the apical compartment in epithelial
cells (Mangeat et al., 1999; Tsukita and Yonemura, 1999;
Gautreau et al., 2000; Bretscher et al., 2002). Specific localiza-
tion of ERM proteins has also been reported at the nodes of
Ranvier in Schwann cells (Melendez-Vasquez et al., 2001;
Gatto et al., 2003). In 
 
Drosophila
 
, the sole member of the ERM
family, 
 
Dmoesin
 
, has been demonstrated to be required for oo-
cyte polarity (Polesello et al., 2002). However, the cellular
compartmentalization in these examples is largely dependent
on interactions with the neighboring cells or matrix. In highly
motile immune cells, in contrast, the dependency of the cell
morphology and polarity formation on the environmental struc-
tural support seems to be relatively weak. Hence, these cells
might possess an intrinsic self-organizing system for plasma
membrane polarization, using ERM proteins as the scaffold
that connects selective transmembrane proteins to factors in-
volved in cytoplasmic polarity.
 
Materials and methods
 
Cells
 
The mouse T cell lymphoma line, EL4.G8, was obtained from the parental
EL4 line by limiting dilution. EL4.G8, BW5147, or X63.653 (P3/X63-
Ag8.653) cells were grown in nonadherent culture dishes in RPMI 1640
medium (Invitrogen) supplemented with 10% FCS. For treatment with phar-
macological inhibitors, the cells were incubated with 0.5 
 
 
 
M staurospo-
rine, 25 
 
 
 
M BIM, 10 
 
 
 
M Y-27632 (Calbiochem), or 10 
 
 
 
M cytochalasin
D (Nacalai Tesque) in the medium for 1 h at 37
 
 
 
C.
 
Antibodies
 
The following antibodies or fluorescent probes were used in this study:
phycoerythrin-anti–mouse CD43 and CD44 (BD Biosciences), FITC–anti-
CD43 (BD Biosciences), Alexafluor 546 phalloidin and Alexafluor 488
goat anti–rabbit IgG (Molecular Probes), anti–
 
 
 
-tubulin (Sigma-Aldrich),
FITC–anti-GM130 (BD Biosciences), anti-GFP (CLONTECH Laboratories,
Inc.), anti–mouse CD44 (KM201; IQ Products), antiezrin (Upstate Biotech-
nology), anti–p-ERM (Cell Signaling Technology), normal rabbit IgG anti-
Dbl (Santa Cruz Biotechnology, Inc.), anti–LFA-1 (FD441.8 hybridoma
culture supernatant), and HRP-anti–rabbit IgG (Jackson ImmunoResearch
Laboratories).
 
Immunofluorescence microscopy
 
For immunofluorescence staining, cells were fixed with 3% PFA in PBS and
permeabilized with 0.2% Triton X-100/PBS or 0.5% saponin/PBS. To de-
tect the intracellular localization of p-ERM, we performed a TCA fixation
method, which inactivates phosphatases and maintains the level of p-ERM
proteins during sample processing (Hayashi et al., 1999), with a slight
modification. In brief, cells were fixed in suspension with 10% TCA solu-
tion for 15 min at room temperature, and were rinsed three times with
PBS. For detection of the posterior cytoplasm, cells were labeled with BO-
DIPY-FL or -TR C
 
5
 
-ceramide (Molecular Probes) for 30 min at 37
 
 
 
C, before
fixation. After being blocked with 5% BSA-PBS, cells were stained with an-
tibodies for 30–60 min. The nucleus was visualized by staining with 0.1
 
 
 
g/ml DAPI. Stained cells were mounted with Permafluor aqueous mount-
ing medium (Immunotech) and examined with confocal laser scanning mi-
croscopes (model MRC-1024 [Bio-Rad Laboratories]; model TSC-SP2
[Leica]). Digital images obtained were processed by Adobe Photoshop
software (Katakai et al., 2002).
 
Counting and measuring uropods and polar caps
 
We determined the number of cells bearing the uropod by counting cells
in the digital images obtained with a phase-contrast microscope (model
TND330; Nikon) equipped with a 40
 
 
 
 objective and a measuring gauge.
Images captured with a 3CCD camera (model C5810; Hamamatsu Pho-
Figure 8. Model of lymphocyte polarization and uropod formation.
During the construction of the motile polarized morphology in lymphocytes
in response to chemoattraction or adhesion signals (directional cues), two
codependent steps are proposed: “posteriorization” of the plasma membrane
mediated by ERM phosphorylation, and “uropod protrusion” mediated by
Rho–ROCK activation. 
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tonics) were prepared with Adobe Photoshop software. The length of the
uropod was determined by measuring the distance between the imaginary
line of the rounded cell body and the tip of the protrusion. Polar caps (indi-
cated by CD44 or GFP localization) formed in drug-treated or transfected
cells were counted under a fluorescence microscope.
 
Plasmids
 
Expression vectors containing cDNAs encoding EGFP-tagged human WT
ezrin, T567A ezrin, and T567D ezrin were provided by Monique Arpin
(Institut Curie, Paris, France) (Gautreau et al., 2000; Coscoy et al.,
2002). The NT fragment 1–366 and CT fragment 466–586 of ezrin were
amplified from full-length ezrin cDNA by PCR, using the following oli-
gonucleotide primers: EzrinNF-EcoRI, 5
 
 
 
-CGTGAATTCCCGAAAATGC-
CGAAACCAATC-3
 
 
 
; EzrinNIR-SalI, 5
 
 
 
-CGTCGTCGACTTCTCTGTTTC-
CAGCTGTTG-3
 
 ; EzrinCF-EcoRI, 5 -CGTGAATTCGTGATGACAGCA-
CCCCCGCCC-3 ; and EzrinCR-SalI, 5 -CGTGTCGACGACAGGCCCTC-
GAACTCGTCG-3 . Dbl-AID was amplified from EL4 cDNA using the
following primer pair: N2-XhoI-F, 5 -CCCTCGAGTGGCATCGAATCAC-
CACTATG-3  and N2-SalI-R, 5 -GGGGTCGACTGATCAGAATTCTTCTCT-
TGG-3 . The PCR products were subcloned into pEGFP-N1 (CLONTECH
Laboratories, Inc.). To construct T567D- AB ezrin, we performed PCR
using a plasmid vector for T567D ezrin-EGFP as a template and the
following primer pair: SmaI-T567DF, 5 -GAAGGCCCAGGCCCGGG-
AGGAGAAGC-3  and AgeI-T567D- ABR, 5 -CCGGACCGGTATGCGC-
TGCTTGGTGTTGCC-3 . The PCR products were subcloned into the
T567D ezrin-EGFP plasmid. Expression vectors for EGFP-tagged WT,
Q63L, and T19N Rho in a pcDNA3 background were a gift from Klaus
Hahn (The Scripps Research Institute, La Jolla, CA) (Subauste et al.,
2000).
Transfection
Cells (10
7 cells per 0.4 ml PBS) were transfected with 30  g of plasmids
in 4-mm-diam cuvettes by electroporation using a Gene Pulser (Bio-Rad
Laboratories) at 380 V and 960  F. After the clump of dead, lysed cells
was removed, the cells were diluted 10-fold in medium (containing 10%
FCS) and analyzed 24 h after electroporation. For stable transfection,
cells electroporated with linearized plasmids were selected with 400  g/
ml G418 in 96-well plates. GFP-positive cells were further enriched by
subcloning via limiting dilution, when necessary. Five stable clones for WT
ezrin, T567A ezrin, and T567D ezrin, and two for NT ezrin, CT ezrin,
and GFP-control vectors, were obtained.
Western blotting
Cells pretreated with or without 10% TCA were lysed in 5  SDS sample
buffer. After the samples were boiled, equal amounts of total lysates were
separated by SDS-PAGE and transferred onto polyvinylidene difluoride
membranes. The membranes were soaked in a blocking solution (5% skim
milk and 0.2% Tween 20-PBS) for 1 h, and then incubated with primary
antibodies for 1 h. After being washed with Tween 20-PBS, membranes
were incubated with appropriate HRP-conjugated secondary antibodies
for 1 h. Specific bands were visualized by an ECL method (ECL
 ; Amer-
sham Biosciences).
Immunoprecipitation
Cells were lysed with RIPA buffer (150 mM NaCl, 50 mM Tris, pH 8.0,
0.1% SDS, 0.5% deoxycholate, 1% NP-40, and protease inhibitors [1
mM PMSF, 2  g/ml leupeptin, 2  g/ml aprotinin, and 2  g/ml pepstatin
A]) on a rotator for 1 h at 4 C. After insoluble materials were removed by
centrifugation, the soluble supernatants were precleared with protein
G–Sepharose 4 fast-flow (Amersham Biosciences). Samples were then im-
munoprecipitated with antibodies and 20  l of protein G beads. Protein
G–bound protein complexes were washed with lysis buffer and eluted by
boiling in sample buffer for SDS-PAGE. The immunoprecipitated proteins
were detected by Western blotting.
Detection of Rho guanine nucleotide exchange activity
To detect Rho-GEF activity associated with ezrin or p-ERM, we used an as-
say system combining immunoprecipitation, an in vitro exchange reaction,
and pull-down detection of activated Rho. More than 3   10
8 cells were
lysed with 2 ml RIPA buffer, and the protein complex was immunopre-
cipitated using an appropriate antibody. Alternatively, specific antibody
(anti–p-ERM or anti-Dbl) was added to the lysate at the preclear step for
the depletion of certain protein complexes. The in vitro exchange reaction
was performed as described previously (Debant et al., 1996), with a
slight modification. 0.5  g of recombinant His6-RhoA (Cytoskeleton, Inc.)
was preloaded with GDP incubating in 100  l of loading buffer (50 mM
Tris-HCl, pH 7.5, 50 mM NaCl, 5 mM EDTA, 1 mM DTT, and 1 mg/ml
BSA) containing 10  M GDP for 20 min at 25 C. After the incubation, the
reaction was quenched with 100  l of stop exchange buffer (50 mM Tris-
HCl, pH 7.5, 10 mM MgCl2, and 1 mM DTT), and then diluted with 1.5
ml of exchange buffer (50 mM Tris-HCl, pH 7.5, 200  M GTP S, and 2
mM MgCl2). 500  l of Rho-GDP solution was transferred to a tube con-
taining the immunoprecipitated protein complex, and then incubated with
gentle agitation on a rocker at 25 C for 20 min. Then, the reaction was
quenched by adding 0.1 volume of stop buffer (50 mM Tris-HCl, pH 7.5,
and 60 mM MgCl2). The amount of Rho-GTP in the reaction solution was
measured by a pull-down method based on specific binding to Rhotekin-
RBD followed by Western blotting using anti-Rho antibody (Rho activation
assay biochem kit; BK306; Cyoskeleton, Inc.). The relative amount of ac-
tive Rho compared with that in the control was calculated by measuring
the band density of Rho and normalized to ezrin density.
Chemotaxis assay
The chemotaxis assay was performed using Transwell chambers (6.5-mm
diam, 5-mm pore size, Costar). 200,000 cells suspended in 100  l of me-
dium were placed into the top chamber, and 600  l of medium contain-
ing 10 ng/ml mouse SDF-1 (PeproTech) was added to the bottom well. Al-
ternatively, cells were pretreated with 1  g/ml pertussis toxin, 0.5  M
staurosporine, 10  M Y-27632 (Calbiochem), or 10  M cytochalasin D
(Nacalai Tesque) in RPMI 1640 medium for 30 min at 37 C. After 4 h of
chemotaxis, cells in the bottom well were collected and the cell number
was counted using a FACScalibur flow cytometer (Becton Dickinson) with
a constant time period (60 s) (Katakai et al., 2002).
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